These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11914564)

  • 21. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
    Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
    Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation.
    Noble PL; Wallace EM; Snijders RJ; Groome NP; Nicolaides KH
    Br J Obstet Gynaecol; 1997 Mar; 104(3):367-71. PubMed ID: 9091018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
    Bersinger NA; Noble P; Nicolaides KH
    Prenat Diagn; 2003 Feb; 23(2):157-62. PubMed ID: 12575025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
    Spencer K; Ong C; Skentou H; Liao AW; H Nicolaides K
    Prenat Diagn; 2000 May; 20(5):411-6. PubMed ID: 10820411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of secretion of pregnancy-associated plasma protein-A (PAPP-A) during pregnancies complicated by fetal aneuploidy, in vivo and in vitro.
    Leguy MC; Brun S; Pidoux G; Salhi H; Choiset A; Menet MC; Gil S; Tsatsaris V; Guibourdenche J
    Reprod Biol Endocrinol; 2014 Dec; 12():129. PubMed ID: 25543334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
    Spencer K; Nicolaides KH
    Prenat Diagn; 2002 Oct; 22(10):877-9. PubMed ID: 12378569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
    Tul N; Novak-Antolic Z
    Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal thyroid function at 11-13 weeks of gestation in fetal trisomies 21 and 18.
    Ashoor G; Maiz N; Cuckle H; Jawdat F; Nicolaides KH
    Prenat Diagn; 2011 Jan; 31(1):33-7. PubMed ID: 21210478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.